Age (SD) years | 65.95 (12.2) |
---|---|
Sex | |
Male | 264(66%) |
Female | 136(34%) |
PS | |
0–1 | 387(96.75%) |
> 1 | 13(3.25%) |
ASA score | |
1–2 | 343(85.75%) |
> 2 | 50(12.5%) |
Missing | 7(1.75%) |
BMI (Kg/m2) | |
< 18 | 14(4.5%) |
18—28 | 283(70.75%) |
> 28 | 97(24.25%) |
Missing | 6 |
History of surgery | |
Yes | 20(5%) |
No | 380(95%) |
Tumor location | |
Median (quartiles) cm | 7(4–11) |
Low | 116(29%) |
Medium | 124(31%) |
Hight | 155(38.75%) |
Missing | 5 |
Neoadjuvant CRT | 283(70.75%) |
pT Stage | |
0–3 | 377(94.25%) |
4 | 22(5.5%) |
Missing | 1 |
M stage | |
M0 | 347(86.75%) |
M1 | 52(13%) |
CRM + | 25(6.25%) |
DRM + | 25(6.25%) |
Conversion rate | 21.75% |